Topical Investigational Drug

· Incyte Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical Investigational Drug, covering 2022-02-08 to 2022-02-08. Get the full timeline:

Most recent: Clinical Trial Update: Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis [Phase 2]